Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies

NCT04349436 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Merkel Cell Carcinoma
Basal Cell Carcinoma
Locally Advanced Cutaneous Squamous Cell Carcinoma
Cancer

Interventions

BIOLOGICAL: RP1, intra-tumoral injection, oncolytic virus

Sponsor

Replimune, Inc.